Development of a sensitive, specific reverse transcriptase polymerase chain reaction-based assay for epithelial tumour cells in effusions
1999

New Method to Detect Cancer Cells in Fluid Samples

Sample size: 110 publication Evidence: high

Author Information

Author(s): Sakaguchi M, Virmani A K, Ashfaq R, Rogers T E, Rathi A, Liu Y, Kodagoda D, Cunningham H T, Gazdar A F

Primary Institution: Hamon Center for Therapeutic Oncology Research, Dallas, TX, USA

Hypothesis

Can a new assay improve the detection of epithelial cancer cells in effusions?

Conclusion

The developed method significantly increases the sensitivity and specificity of detecting malignant cells in effusions.

Supporting Evidence

  • The method detected 94% of cytologically positive effusions for malignant cells.
  • 11% of cytologically negative samples were positive for EGP-2, indicating potential undiagnosed cancer.

Takeaway

Researchers created a new test that helps find cancer cells in body fluids, making it easier to diagnose cancer.

Methodology

The study used a two-stage molecular-based assay combining immunomagnetic bead selection and RT-PCR detection of EGP-2 RNA.

Limitations

The method may not be effective for patients who have recently undergone chemotherapy.

Participant Demographics

The study included 110 cases of pleural and peritoneal effusions, with some patients having known carcinoma.

Digital Object Identifier (DOI)

10.1038/sj.bjc.6690065

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication